Search Results - "GUILBAUD, Nicolas"

Refine Results
  1. 1

    Melanoma chemotherapy leads to the selection of ABCB5-expressing cells by Chartrain, Marine, Riond, Joëlle, Stennevin, Aline, Vandenberghe, Isabelle, Gomes, Bruno, Lamant, Laurence, Meyer, Nicolas, Gairin, Jean Edouard, Guilbaud, Nicolas, Annereau, Jean Philippe

    Published in PloS one (24-05-2012)
    “…Metastatic melanoma is the most aggressive skin cancer. Recently, phenotypically distinct subpopulations of tumor cells were identified. Among them,…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Actinic keratosis modelling in mice: A translational study by Pillon, Arnaud, Gomes, Bruno, Vandenberghe, Isabelle, Cartron, Valérie, Cèbe, Patrick, Blanchet, Jean-Christophe, Sibaud, Vincent, Guilbaud, Nicolas, Audoly, Laurent, Lamant, Laurence, Kruczynski, Anna

    Published in PloS one (29-06-2017)
    “…Actinic keratoses (AK) are pre-malignant cutaneous lesions caused by prolonged exposure to ultraviolet radiation. As AKs lesions are generally accepted to be…”
    Get full text
    Journal Article
  5. 5

    Synthesis and biological evaluation of (-)-6-O-desmethylcryptopleurine and analogs by Liéby-Muller, Frédéric, Marion, Frédéric, Schmitt, Philippe, Annereau, Jean-Philippe, Kruczynski, Anna, Guilbaud, Nicolas, Bailly, Christian

    Published in Bioorganic & medicinal chemistry letters (15-01-2015)
    “…(-)-Cryptopleurine 1 is one of the most potent anti-proliferative member of the phenanthroquinolizidine class of alkaloids. We report here the synthesis of…”
    Get full text
    Journal Article
  6. 6

    An integrated Drosophila model system reveals unique properties for F14512, a novel polyamine-containing anticancer drug that targets topoisomerase II by Chelouah, Sonia, Monod-Wissler, Caroline, Bailly, Christian, Barret, Jean-Marc, Guilbaud, Nicolas, Vispé, Stéphane, Käs, Emmanuel

    Published in PloS one (10-08-2011)
    “…F14512 is a novel anti-tumor molecule based on an epipodophyllotoxin core coupled to a cancer-cell vectoring spermine moiety. This polyamine linkage is assumed…”
    Get full text
    Journal Article
  7. 7

    Tumor penetration of gefitinib (Iressa), an epidermal growth factor receptor tyrosine kinase inhibitor by McKillop, David, Partridge, Elizabeth A, Kemp, John V, Spence, Mike P, Kendrew, Jane, Barnett, Sharon, Wood, Phillippa G, Giles, Petrina B, Patterson, Andrew B, Bichat, Francis, Guilbaud, Nicolas, Stephens, Trevor C

    Published in Molecular cancer therapeutics (01-04-2005)
    “…The relative distribution of gefitinib-related material in nude mice bearing s.c. human tumor xenografts and in an orthotopic rat lung tumor model was…”
    Get full text
    Journal Article
  8. 8

    CD10 expression by melanoma cells is associated with aggressive behavior in vitro and predicts rapid metastatic progression in humans by Thomas-Pfaab, Marianne, Annereau, Jean-Philippe, Munsch, Coline, Guilbaud, Nicolas, Garrido, Ignacio, Paul, Carle, Brousset, Pierre, Lamant, Laurence, Meyer, Nicolas

    Published in Journal of dermatological science (01-02-2013)
    “…Abstract Background No biological or molecular marker of primary melanoma tumor cells has been shown to predict clinical outcome in melanoma. Objective To…”
    Get full text
    Journal Article
  9. 9

    Optical imaging of disseminated leukemia models in mice with near-infrared probe conjugated to a monoclonal antibody by Pesnel, Sabrina, Pillon, Arnaud, Créancier, Laurent, Lerondel, Stéphanie, Le Pape, Alain, Recher, Christian, Demur, Cécile, Guilbaud, Nicolas, Kruczynski, Anna

    Published in PloS one (27-01-2012)
    “…The assessment of anticancer agents to treat leukemia needs to have animal models closer to the human pathology such as implantation in immunodeficient mice of…”
    Get full text
    Journal Article
  10. 10

    Pursaethosides A-E, triterpene saponins from Entada pursaetha by Tapondjou, A.L, Miyamoto, T, Mirjolet, J.F, Guilbaud, N, Lacaille-Dubois, M.A

    “…Five new triterpenoid saponins, pursaethosides A-E (1-5), were isolated from the n-BuOH extract of the seed kernels of Entada pursaetha along with the known…”
    Get full text
    Journal Article
  11. 11

    Marked Antitumor Activity of a New Potent Acronycine Derivative in Orthotopic Models of Human Solid Tumors by GUILBAUD, Nicolas, KRAUS-BERTHIER, Laurence, ATASSI, Ghanem, HICKMAN, John, PIERRE, Alain, MEYER-LOSIC, Florence, MALIVET, Virginie, CHACUN, Christine, JAN, Michel, TILLEQUIN, Francois, MICHEL, Sylvie, KOCH, Michel, PFEIFFER, Bruno

    Published in Clinical cancer research (01-08-2001)
    “…S 23906-1 is a novel acronycine derivative selected on the basis of its potency in vitro . We investigated the antitumor activity of S 23906-1 against several…”
    Get full text
    Journal Article
  12. 12

    Histology and Sensitivity to Anticancer Drugs of Two Human Non-Small Cell Lung Carcinomas Implanted in the Pleural Cavity of Nude Mice by KRAUS-BERTHIER, L, JAN, M, GUILBAUD, N, NAZE, M, PIERRE, A, ATASSI, G

    Published in Clinical cancer research (01-01-2000)
    “…We have established two metastatic models of human non-small cell lung carcinoma (NSCLC)—the NCI-H460 large-cell carcinoma and the A549 adenocarcinoma—by…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Synthesis of N, N′-disubstituted 3-aminobenzo[ c] and [ d]azepin-2-ones as potent and specific farnesyl transferase inhibitors by Le Diguarher, Thierry, Ortuno, Jean-Claude, Shanks, David, Guilbaud, Nicolas, Pierré, Alain, Raimbaud, Eric, Fauchère, Jean-Luc, Hickman, John A, Tucker, Gordon C, Casara, Patrick J

    Published in Bioorganic & medicinal chemistry letters (09-02-2004)
    “…A structure–activity study was performed by synthesis on N, N′-disubstitution of 3-aminobenzo[ c] and [ d]azepin-2-one 2 and 3 to afford potent and specific…”
    Get full text
    Journal Article
  15. 15

    Comparison of the pharmacological profile of an olivacine derivative and a potential prodrug by KRAUS-BERTHIER, Laurence, GUILBAUD, Nicolas, LEONCE, Stéphane, PARKER, Tracy, GENISSEL, Patrick, GUILLONNEAU, Claude, GOLDSTEIN, Solo, ATASSI, Ghanem, PIERRE, Alain

    Published in Cancer chemotherapy and pharmacology (01-08-2002)
    “…The new olivacine derivative S 16020-2 (NSC-659687) has entered clinical trials on the basis of a marked antitumor activity in experimental models. Amongst the…”
    Get full text
    Journal Article
  16. 16

    The DNA-Binding Polyamine Moiety in the Vectorized DNA Topoisomerase II Inhibitor F14512 Alters Reparability of the Consequent Enzyme-Linked DNA Double-Strand Breaks by Bombarde, Oriane, Larminat, Florence, Gomez, Dennis, Frit, Philippe, Racca, Carine, Gomes, Bruno, Guilbaud, Nicolas, Calsou, Patrick

    Published in Molecular cancer therapeutics (01-10-2017)
    “…Poisons of topoisomerase II (TOP2) kill cancer cells by preventing religation of intermediate DNA breaks during the enzymatic process and thus by accumulating…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20

    Cytotoxicity and cell death mechanisms induced by the polyamine-vectorized anti-cancer drug F14512 targeting topoisomerase II by Brel, Viviane, Annereau, Jean-Philippe, Vispé, Stéphane, Kruczynski, Anna, Bailly, Christian, Guilbaud, Nicolas

    Published in Biochemical pharmacology (15-12-2011)
    “…The polyamines transport system (PTS) is usually enhanced in cancer cells and can be exploited to deliver anticancer drugs. The spermine-conjugated…”
    Get full text
    Journal Article